These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12071813)

  • 1. Infantile hemangioma: clinical resolution with 5% imiquimod cream.
    Martinez MI; Sanchez-Carpintero I; North PE; Mihm MC
    Arch Dermatol; 2002 Jul; 138(7):881-4; discussion 884. PubMed ID: 12071813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topical treatment of melanoma skin metastases with imiquimod].
    Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
    Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
    Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
    J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod therapy for cutaneous T-cell lymphoma.
    Do JH; McLaughlin SS; Gaspari AA
    Skinmed; 2003; 2(5):316-8. PubMed ID: 14673267
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.
    Hannuksela-Svahn A; Nordal E; Christensen OB
    Acta Derm Venereol; 2000; 80(5):381-2. PubMed ID: 11200841
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
    Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
    Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involution of infantile haemangiomas after imiquimod 5% cream.
    Barry RB; Hughes BR; Cook LJ
    Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
    Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
    Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
    Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
    Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
    Hyde MA; Hadley ML; Tristani-Firouzi P; Goldgar D; Bowen GM
    Arch Dermatol; 2012 May; 148(5):592-6. PubMed ID: 22431716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
    Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
    Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma.
    Tiodorovic-Zivkovic D; Argenziano G; Catricalà C; Ferrara G; Giorgio CM; Moscarella E; Zalaudek I
    Eur J Dermatol; 2011; 21(3):410-1. PubMed ID: 21515443
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
    Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
    Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
    Oster-Schmidt C
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod and the treatment of cutaneous T-cell proliferative diseases: at the threshold.
    Herbert WC
    Skinmed; 2003; 2(5):273-4. PubMed ID: 14673259
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
    Vun Y; Siller G
    Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
    Chapman MS; Spencer SK; Brennick JB
    Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryosurgery during imiquimod cream treatment ("immunocryosurgery") for Bowen's disease of the skin: a case series.
    Gaitanis G; Mitsou G; Tsiouri G; Alexis I; Bassukas ID
    Acta Derm Venereol; 2010 Sep; 90(5):533-4. PubMed ID: 20814639
    [No Abstract]   [Full Text] [Related]  

  • 19. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
    Marks R; Gebauer K; Shumack S; Amies M; Bryden J; Fox TL; Owens ML;
    J Am Acad Dermatol; 2001 May; 44(5):807-13. PubMed ID: 11312429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.